Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/17/2011 | WO2011141825A1 Meganuclease variants cleaving a dna target sequence from the rhodopsin gene and uses thereof |
11/17/2011 | WO2011141705A1 Novel cationic lipids and methods of use thereof |
11/17/2011 | WO2011141704A1 Novel cyclic cationic lipids and methods of use |
11/17/2011 | WO2011141703A1 Compositions and methods for silencing apolipoprotein b |
11/17/2011 | WO2011141558A1 Recombinant vector for producing and secreting amino acid sequences of interest by propionibacteria and applications thereof |
11/17/2011 | WO2011141528A1 Method for extracellular production of recombinant biomolecules in a microorganism |
11/17/2011 | WO2011141499A1 Growth promoting fusion proteins |
11/17/2011 | WO2011141451A1 Dna based multivalent vaccine against mycobacterium tuberculosis, encoding ag85a, tb9.8, tb10.4 and acr2 antigens. |
11/17/2011 | WO2011141373A1 Method for transfecting a eukaryotic cell |
11/17/2011 | WO2011141188A1 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth |
11/17/2011 | WO2011141027A1 A METHOD OF STABILIZING mRNA |
11/17/2011 | WO2011140997A1 Transgenic drosophila model of alzheimer's disease and use thereof in drug screening |
11/17/2011 | WO2011140644A1 Polyacetal or polyketal and ether polymers |
11/17/2011 | WO2011140639A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion |
11/17/2011 | WO2011140638A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1 |
11/17/2011 | WO2011140627A1 Nucleic acid-containing lipid particles and related methods |
11/17/2011 | WO2011140601A1 Nucleic acid molecules for producing triterpenoid hydrocarbons |
11/17/2011 | WO2011120156A8 Polyamine-containing polymers and methods of synthesis and use |
11/17/2011 | WO2011114312A9 Plants having enhanced yield-related traits and method for making same |
11/17/2011 | WO2011106104A3 Methods and compositions for the detection and treatment of cancer involving mirnas and mirna inhibitors and targets |
11/17/2011 | WO2011105902A3 Antagonists of complement component 8-beta (c8-beta) and uses thereof |
11/17/2011 | WO2011105900A3 Antagonists of complement component 8-alpha (c8-alpha) and uses thereof |
11/17/2011 | WO2011094356A3 Methods and kits used in the detection of fungus |
11/17/2011 | WO2011091317A3 Engineered landing pads for gene targeting in plants |
11/17/2011 | WO2011091311A3 Excision of transgenes in genetically modified organisms |
11/17/2011 | WO2011089574A4 Methods of generating modified polynucleotide libraries and methods of using the same for directed protein evolution |
11/17/2011 | WO2011088443A3 Co-existing libraries for developing complex microbial phenotypes |
11/17/2011 | WO2011087854A3 Sequences and uses thereof for virus resistance in plants |
11/17/2011 | WO2011087804A3 Peptide- polynucleotide compositions for transfecting a cell with dna and for treating a neurodegenerative disease |
11/17/2011 | WO2011085095A3 Enhanced protein expression |
11/17/2011 | WO2011084647A3 Toxin-immunity system |
11/17/2011 | WO2011084324A3 Novel bacillus thuringiensis gene with lepidopteran activity |
11/17/2011 | WO2011082409A3 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
11/17/2011 | WO2011081343A3 Transgenic pig in which ho-1 genes and tnfr1-fc genes are simultaneously expressed, and method for producing same |
11/17/2011 | WO2011080674A3 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
11/17/2011 | WO2011079263A3 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
11/17/2011 | WO2011079261A3 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
11/17/2011 | WO2011077133A3 Method of treatment and screening method |
11/17/2011 | WO2011071931A3 Rna preparations comprising purified modified rna for reprogramming cells |
11/17/2011 | WO2011068909A3 Aptamer cell compositions |
11/17/2011 | WO2011063098A3 Genetic markers for weight management and methods of use thereof |
11/17/2011 | WO2011063055A3 Engineering microbes for efficient production of chemicals |
11/17/2011 | WO2011060272A3 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
11/17/2011 | WO2011060080A3 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes |
11/17/2011 | WO2011059505A3 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
11/17/2011 | WO2011057304A3 Microrna signatures differentiating uterine and ovarian papillary serous tumors |
11/17/2011 | WO2011049409A3 Mannose 6-phosphate isomerase, mutants thereof, and use thereof |
11/17/2011 | WO2011049334A3 OsLRP GENE FOR INCREASING PLANT DISEASE RESISTANCE, AND USE THEREOF |
11/17/2011 | WO2011044336A3 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
11/17/2011 | WO2011019763A3 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases |
11/17/2011 | WO2011008117A3 The use of a sirna oligonucleotide |
11/17/2011 | WO2010109053A8 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
11/17/2011 | WO2010012667A8 Micro-rna mediated modulation of colony stimulating factors |
11/17/2011 | US20110283426 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof |
11/17/2011 | US20110283425 Soybean plants having superior agronomic performance and methods for their production |
11/17/2011 | US20110283424 Gene Encoding Lignan Methylation Enzyme |
11/17/2011 | US20110283423 Polypeptides Having Carboxypeptidase Activity And Polynucleotides Encoding Same |
11/17/2011 | US20110283422 Polypeptides Having Aspartic Endopeptidase Activity And Polynucleotides Encoding Same |
11/17/2011 | US20110283420 Plants having enhanced yield-related traits and a method for making the same |
11/17/2011 | US20110283419 Regulation of Cotton Fiber Growth by Extracellular Nucleotides and Ectoapyrases |
11/17/2011 | US20110283417 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
11/17/2011 | US20110283416 Methods for plant fiber characterization and identification |
11/17/2011 | US20110283414 Soybean Cultivar 95092896 |
11/17/2011 | US20110283413 Soybean Cultivar 99497033 |
11/17/2011 | US20110283405 Plants and seeds of hybrid corn variety ch728664 |
11/17/2011 | US20110283404 Plants and seeds of hybrid corn variety ch637374 |
11/17/2011 | US20110283401 Soybean Cultivar S090243 |
11/17/2011 | US20110283400 Soybean cultivar 92394228 |
11/17/2011 | US20110283399 Soybean cultivar 98433118 |
11/17/2011 | US20110283398 Soybean cultivar 96462908 |
11/17/2011 | US20110283397 Plants and seeds of hybrid corn variety ch396198 |
11/17/2011 | US20110283396 Plants and seeds of hybrid corn variety ch957322 |
11/17/2011 | US20110283395 Plants and seeds of hybrid corn variety ch434101 |
11/17/2011 | US20110283393 Soybean cultivar s090253 |
11/17/2011 | US20110283392 Soybean cultivar 97274007 |
11/17/2011 | US20110283391 Soybean Cultivar 90362556 |
11/17/2011 | US20110283390 Soybean Cultivar 96292716 |
11/17/2011 | US20110283389 Soybean Cultivar 99466158 |
11/17/2011 | US20110283388 Soybean Cultivar 93397033 |
11/17/2011 | US20110283387 Soybean Cultivar 90202016 |
11/17/2011 | US20110283386 Soybean Cultivar S090250 |
11/17/2011 | US20110283385 Plants and seeds of corn variety cv032267 |
11/17/2011 | US20110283383 Plants and seeds of corn variety cv702540 |
11/17/2011 | US20110283382 Plants and seeds of corn variety cv556014 |
11/17/2011 | US20110283381 Plants and seeds of corn variety cv353100 |
11/17/2011 | US20110283380 Plants and seeds of corn variety cv502609 |
11/17/2011 | US20110283379 Plants and seeds of corn variety cv385683 |
11/17/2011 | US20110283377 Compositions, organisms, systems, and methods for expressing a gene product in plants |
11/17/2011 | US20110283376 Methods of Modifying Eukaryotic Cells |
11/17/2011 | US20110283375 Transgenic Prothrombin And Related Thrombin Precursors And Transgenics, Methods, Compositions, Uses And The Like Relating Thereto |
11/17/2011 | US20110283373 Mutant protease biosensors with enhanced detection characteristics |
11/17/2011 | US20110283372 Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof |
11/17/2011 | US20110282037 Antibody preparation |
11/17/2011 | US20110282036 Bsa-specific antibodies |
11/17/2011 | US20110282035 Rage Fusion Proteins, Formulations And Methods Of Use Thereof |
11/17/2011 | US20110281937 Methods and compositions for treating neuropathic and neurodegenerative conditions |
11/17/2011 | US20110281931 Rna sequence-specific mediators of rna interference |
11/17/2011 | US20110281803 Sulfatase enzymes |
11/17/2011 | US20110281800 Recombinant fusion proteins to growth hormone and serum albumin |
11/17/2011 | US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses |